Einen kosmetischen Stoff über Märkte hinweg vergleichen
Geben Sie einen INCI-Namen, eine chemische Bezeichnung, eine CAS- oder EC-Nummer ein. Das Werkzeug verbindet Belege aus EU-Anhängen, verknüpfte Inhaltsstoffidentitäten und eigenständige amtliche Ländereinträge zu einem Vergleich.
Ein fehlender lokaler Eintrag wird als Belegslücke angezeigt, niemals als Zulassung oder Sicherheitsfeststellung.
Die exakte Identität suchen
MIRODENAFIL
Übereinstimmende regulatorische Belege wurden in 0 von 13 Marktdatensätzen gefunden.
Belege zur ermittelten Identität
1 übereinstimmender oder gemeldeter Name
Regulatorische Belege nach Markt
Der Status ist der stärkste übereinstimmende Eintrag in unserem Datenbestand. Öffnen Sie die Einträge, um genaue Bedingungen und rechtlichen Geltungsbereich zu prüfen.
| Markt | Ergebnis | Einträge | Datensatzabdeckung | Nächster Schritt |
|---|---|---|---|---|
| European Union EU | Kein Treffer gefunden | 0 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review. |
| Great Britain GB | Kein Treffer gefunden | 0 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework. |
| Canada CA | Kein Treffer gefunden | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Kein Treffer gefunden | 0 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | The searchable spreadsheet is an aid; the legal Group Standard and incorporated notices remain authoritative. |
| ASEAN ASEAN | Kein Treffer gefunden | 0 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Regional annex coverage does not replace member-state implementation dates, notifications or national deviations. |
| China CN | Kein Treffer gefunden | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | Kein Treffer gefunden | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Kein Treffer gefunden | 0 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Korean source wording is canonical and other positive lists/notices may still apply to the formulation. |
| United States US | Kein Treffer gefunden | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | Kein Treffer gefunden | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | Kein Treffer gefunden | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | Kein Treffer gefunden | 0 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | The standards are separate controlled publications; absence from a locally indexed excerpt is not permission. |
| Saudi Arabia SA | Kein Treffer gefunden | 0 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply. |
Den amtlichen Verifizierungsablauf abschließen
Belege zum Inhaltsstoff sind nur eine Ebene. Diese marktspezifischen Schritte benennen die verbleibenden Prüfungen vor einer Compliance-Entscheidung.
European Union · Complete annex dataset
- Confirm the exact INCI/CAS/EC identity.
- Review every matching Annex II–VI row and its conditions.
- Check SCCS opinions, CMR/nanomaterial rules and later amendments.
- Verify product classification, claims, labelling and responsible-person duties.
Great Britain · Complete consolidated annex dataset
- Confirm INCI/CAS/EC identity.
- Review every current GB Annex II–VI match.
- Check commencement dates and later statutory instruments.
- Verify SCPN, responsible-person, safety-report and labelling duties.
Canada · Complete Hotlist snapshot
- Search English/French names and CAS identifiers.
- Apply every restriction, concentration and label warning.
- Check Food and Drugs Act/Cosmetic Regulations requirements.
- Recheck the current Hotlist before notification or sale.
New Zealand · Complete schedules dataset
- Search exact identity across Schedules 4–8.
- Apply use, concentration and warning conditions.
- Check hazardous-substance classification and Group Standard scope.
- Confirm the latest legal instrument, not only the spreadsheet.
ASEAN · Complete regional annex dataset
- Search all ACD annexes by name and identifiers.
- Apply product type, maximum level and warning conditions.
- Confirm the target member state's adoption and transition date.
- Complete the local notification and responsible-company requirements.
China · Complete prohibited catalogues plus official-source workflow
- Search the current NMPA IECIC List I and List II by Chinese name and identity.
- Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
- Review technical purpose, use history and any monitoring period.
- Confirm Chinese labelling, safety assessment and filing/registration duties.
Japan · Complete Standards appendices dataset
- Search Japanese/English identity and CAS where present.
- Apply category and maximum-amount conditions.
- Check later MHLW notices against the Japanese source.
- Verify marketing licence, notification, labelling and quasi-drug classification.
South Korea · Complete current appendix dataset
- Match the Korean canonical substance name and identifiers.
- Review all Appendix 1 and 2 matches and conditions.
- Check functional-cosmetic and positive-list requirements where applicable.
- Confirm current MFDS notice, responsible seller and label obligations.
United States · Complete enumerated federal ingredient rules
- Search Part 700 and all relevant colour-additive parts.
- Confirm colour additive identity, permitted uses, limits and certification status.
- Assess safety and adulteration under the FD&C Act.
- Complete MoCRA facility/product, adverse-event and label obligations where applicable.
Australia · Complete cosmetic-relevant Poisons Standard subset plus official workflow
- Decide whether the product is a cosmetic or therapeutic good.
- Check the current Poisons Standard for every ingredient.
- Search AICIS Inventory terms and assessment certificates by exact identity.
- Determine introduction category, registration, reporting, records and labelling duties.
Brazil · Complete prohibited dataset plus current restricted-list workflow
- Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
- Check the consolidated prohibited list including RDC 1.030/2026 changes.
- Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
- Verify Mercosur incorporation, regularisation, labelling and transition periods.
India · Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
- Confirm product class and current Cosmetics Rules/gazette amendments.
- Check all applicable parts of IS 4707 by exact identity.
- Apply Schedule S/other finished-product standards where relevant.
- Verify licence/import registration, labelling and testing requirements.
Saudi Arabia · Complete official list index
- Search names and CAS across both SFDA lists.
- Open the cited restricted-entry detail and apply every condition.
- Check current SFDA/GSO technical regulations and updates.
- Complete eCosma notification, label and responsible-party requirements.
Was dieser Vergleich entscheiden kann und was nicht
1. Identität ermitteln
CAS- und EC-Token werden exakt extrahiert. Namenssuchen verwenden normalisierte amtliche Namen und verknüpfte Identitäten.
2. Belege vergleichen
Der stärkste übereinstimmende Status und die direkten Einträge werden für jeden unterstützten Markt getrennt angezeigt.
3. Verifizierung abschließen
Produktart, Konzentration, Reinheit, Warnhinweise, Angaben, Einstufung und spätere Änderungen erfordern weiterhin eine amtliche Prüfung.